【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 Nephrology and Urology Devices 10
3.1.1 Renal Dialysis Equipment 10
4 Company Snapshot 11
4.1 Key Facts 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 Business Overview 12
4.5 Major Products and Services 13
4.5.1 Overview 13
5 History 14
6 Competitors 16
7 Competitive Landscape 17
7.1 Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 17
7.2 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Region, Market Share (2011) 19
7.3 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Country, Market Share (2011) 20
8 Key Employees 22
9 Key Employee Biographies 23
10 Company Statement 24
11 Locations And Subsidiaries 27
11.1 Head Office 27
11.2 Other Locations & Subsidiaries 27
12 Financial Deals Landscape 28
12.1 NxStage Medical, Inc., Deals Volume Summary, 2007 to YTD 2013 28
13 NxStage Medical, Inc., Deals Summary By Region, 2007 to YTD 2013 29
14 NxStage Medical, Inc. Detailed Deal Summary 31
14.1 Partnerships 31
14.1.1 Asahi Kasei Kuraray Medical Enters Into Licensing Agreement With NxStage Medical 31
14.1.2 NxStage Medical Enters Into Distribution Agreement With Dirinco 32
14.1.3 Medisystems Extends Supply And Distribution Agreement With Fenwal 33
14.1.4 Medisystems Enters Into An Agreement With Gambro 34
14.1.5 NxStage Medical Signs An Agreement With Kimal 35
14.1.6 NxStage Medical and DaVita Enter Into An Agreement For Home Hemodialysis 36
14.2 Equity Offering 37
14.2.1 NxStage Medical Completes Public Offering Of Common Stock For $66.1 Million 37
14.2.2 NxStage Medical Completes Private Placement Of $43 Million 38
14.2.3 NxStage Completes Private Placement Of $20 Million 39
14.3 Acquisition 40
14.3.1 NxStage Medical Acquires Medisystems 40
15 Recent Developments 41
15.1 Strategy And Business Planning 41
15.1.1 Oct 16, 2012: NxStage Opens New Headquarters In Lawrence, Massachusetts 41
15.1.2 Jun 17, 2009: NxStage Signs Distribution Agreement With Gambro 41
15.2 Financial Announcements 42
15.2.1 Nov 08, 2012: NxStage Reports Revenue Of $61.12m In Q3 2012 42
15.2.2 Aug 08, 2012: NxStage Reports Revenue Of $59m In Q2 2012 42
15.2.3 May 08, 2012: NxStage Reports Revenue Of $57m In Q1 2012 43
15.2.4 Feb 29, 2012: NxStage Reports Revenue Of $217.3m In 2011 44
15.2.5 Nov 03, 2011: NxStage Reports Revenues Of $559m In Q3 2011 45
15.2.6 Aug 03, 2011: NxStage Reports Revenues Of $53.8m In Q2 2011 46
15.2.7 May 04, 2011: NxStage Reports Revenues Of $50.6m In Q1 2011 46
15.2.8 Feb 17, 2011: NxStage Reports Revenues Of $179.2m In 2010 47
15.2.9 Nov 04, 2010: NxStage Reports Revenues Of $45m In Q3 2010 48
15.2.10 Jul 23, 2010: NxStage Reports Revenues Of $44m In Q2 2010 48
15.2.11 May 05, 2010: NxStage Reports Revenues Of $40.4 Million In Q1 2010 49
15.2.12 Feb 25, 2010: NxStage Reports Revenue Of $148.7 Million In 2009 49
15.2.13 Nov 05, 2009: NxStage Reports Net Revenue Of $38 Million In Q3 2009 50
15.2.14 Aug 05, 2009: NxStage Reports Revenues Of $36.4 Million In Q2 2009 51
15.2.15 May 08, 2009: NxStage Posts Net Loss Of $12.2 Million In Q1 2009 52
15.2.16 Mar 12, 2009: NxStage Reports 2008 Results 53
15.2.17 Feb 03, 2009: NxStage To Report 2008 Results 54
15.2.18 Nov 03, 2008: NxStage Reports 3Q 2008 Results 54
15.2.19 Aug 05, 2008: NxStage Reports 2Q 2008 Results 56
15.2.20 May 12, 2008: NxStage Reports Q1 2008 Results 57
15.2.21 Feb 12, 2008: NxStage Reports Q4 2007 Results 58
15.2.22 Nov 02, 2007: NxStage Reports Q3 2007 Results 60
15.2.23 Aug 02, 2007: NxStage Reports Q2 2007 Results 60
15.2.24 May 08, 2007: NxStage Reports Q1 2007 Results 61
15.2.25 Feb 15, 2007: NxStage Reports Q4 2006 Results 62
15.3 Corporate Communications 63
15.3.1 Jul 12, 2011: NxStage Medical Appoints Barry Straube To Board 63
15.3.2 Apr 27, 2011: NxStage Medical Appoints Michael Miller As President, International 63
15.3.3 Jan 24, 2011: NxStage Appoints Nancy Ham To Board And Announces Resignation Of Board Member Jonathan Silverstein 64
15.3.4 Dec 20, 2010: NxStage Promotes Joseph Turk As President, North America 64
15.3.5 Feb 23, 2010: NxStage Appoints Elise A. Tordella As VP And General Manager 65
15.3.6 Jan 19, 2010: NxStage Appoints John Mullen As Vice President And General Manager, International 65
15.3.7 Oct 28, 2008: NxStage Announces Board Changes 66
15.3.8 Jul 24, 2008: NxStage Appoints New Board Member 66
15.3.9 Mar 31, 2008: NxStage Appoints Senior Vice President, Manufacturing Operations 67
15.3.10 Feb 28, 2008: NxStage Appoints CCMA 67
15.4 Government and Public Interest 68
15.4.1 May 09, 2011: NxStage Supports Initiative By Patient Advocacy Groups To Educate Policymakers About Benefits Of Frequent Home Hemodialysis 68
15.4.2 Nov 22, 2010: Landmark Study In New England Journal Of Medicine Documents Significant Clinical Advantages Of More Frequent Hemodialysis: NxStage 68
15.5 Product News 69
15.5.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 69
15.5.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 70
15.5.3 Aug 15, 2011: NxStage Announces Seven Year Anniversary Of IU Health’s Home Hemodialysis Program And Patient Milestones 71
15.5.4 Aug 02, 2011: NxStage Patient Advocate Jim Smith Begins West Coast Home Hemodialysis Tour With NxStage System 71
15.5.5 Jun 13, 2011: NxStage Announces Successful Kidney Transplant With NxStage System One 72
15.5.6 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 73
15.5.7 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 73
15.5.8 Feb 21, 2011: Independent Study Reports 50% Smaller Carbon Footprint With NxStage System One Versus Standard In-Center Hemodialysis Machines: NxStage 74
15.5.9 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 75
15.5.10 Feb 17, 2011: NxStage Announces Over 5,000 Patients Using System One For Home Hemodialysis 76
15.5.11 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 76
15.5.12 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 77
15.5.13 Feb 03, 2010: NxStage Forms Alliance With Nordic For Distribution Of NxStage System One And PureFlow SL Dialysate Preparation System 78
15.5.14 Dec 15, 2009: Group Of NxStage Home Hemodialysis Patients Plans Conventional Caribbean Cruise Trip With NxStage System One 78
15.5.15 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 79
15.5.16 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 80
15.5.17 Nov 03, 2008: NxStage Achieves Milestone With 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 80
15.5.18 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 80
15.6 Product Approvals 81
15.6.1 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 81
15.6.2 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 81
15.7 Clinical Trials 82
15.7.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 82
15.7.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 82
15.7.3 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 83
15.7.4 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 84
15.7.5 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 85
15.7.6 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 86
15.7.7 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 87
15.7.8 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 87
15.8 Other Significant Developments 87
15.8.1 Jul 26, 2011: NxStage Signs Five-Year Agreement With Theradial For Distribution Of System One Home Hemodialysis System In France 87
15.8.2 Jun 27, 2011: NxStage Medical Signs Lease For New Headquarters 88
15.8.3 Nov 30, 2010: NxStage Medical’s Medisystems Division Signs Distribution Agreement With Metro Medical 88
15.8.4 Jul 19, 2010: NxStage Commercializes NxStage System One And Certain Of Company’s In-Center Products In Italy Through Spindial 88
15.8.5 Apr 12, 2010: NxStage Medical’s Medisystems Division Expands Supply Agreement With RAI 89
15.8.6 Sep 14, 2009: NxStage Medical Signs Three-Year Supply Agreement With Reliant Renal Care 90
15.8.7 Jul 21, 2009: NxStage Extends Medisystems Needle Supply And Distribution Agreement With Fenwal 90
15.8.8 Jun 17, 2009: NxStage Signs Five-Year Distribution Agreement With Gambro 91
15.8.9 Jun 01, 2009: NxStage Expands Supply Agreement With B. Braun To Include Streamline Technology 91
15.8.10 May 07, 2009: NxStage And Kimal Announce First International Distribution of NxStage’s Home Hemodialysis And Critical Care Systems 92
15.8.11 Feb 27, 2009: iSirona Signs Agreement With NxStage 92
15.8.12 Oct 21, 2008: NxStage Signs Product Supply Contract With RAI 93
15.8.13 Sep 04, 2008: NxStage Extends Supply Contract With DaVita To Supply Blood Tubing Sets 93
15.8.14 Jan 07, 2008: NxStage Signs Supply Agreement With DaVita 93
16 Appendix 94
16.1 Research Methodology 95
16.2 Secondary Research 95
16.3 Primary Research 95
16.4 Models 96
16.5 Forecasts 96
16.6 Expert Panels 96
16.7 GlobalData Consulting 96
16.8 Currency Conversion 97
16.9 Contact Us 98
16.10 Disclaimer 98
【レポート販売概要】
■ タイトル：NxStage Medical, Inc.：市場シェア分析■ 英文：NxStage Medical, Inc. Market Share Analysis
■ 発行日：2013年1月25日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160147
■ 調査対象地域：グローバル
- アメリカの個人用防護具（PPE）市場2016-2020About PPE PPE is a specially designed wearable gear that offers protection from workplace hazards such as chemicals, biohazards, fire, and electrical hazards. It constitutes a range of products with distinct functions — safety gloves for hand protection, safety eye wears for eye protection, ear muffs and ear plugs for hearing protection, safety harnesses for fall protection and so on. It is used a …
- イスラム旅行の世界市場About Islamic Travel Tourism is an elaborate concept that houses an array of considerations with respect to the needs and benefits of the tourists. Every individual tourist visits a particular destination with a destined objective and purpose. Consumers have a level of expectation, desire, and focus while traveling to a particular place and this aspect varies from each individual tourist to other. …
- 産業用トラックの世界市場：倉庫トラック、ICトラック、電気トラックIndustrial trucks are used to transfer materials over variable paths without any restrictions on the area covered. It offers vertical movement if the truck has lifting capabilities. Industrial trucks are used when there is insufficient flow volume and the usage of a conveyor cannot be justified. It provides more flexibility in movement than conveyors and cranes. Industrial trucks are not permitted …
- 食品サービスの世界市場2016-2020About the Foodservice Market Foodservice refers to the sale of foods and beverages that have been prepared out-of-home for immediate consumption either on the premises from where they are purchased or for takeaway and home delivery. Over the years, commercial foodservice places like restaurants and cafés have emerged as a convenient place for teenagers, families, and young working professionals to …
- ビルディングインフォメーションモデリングソフトウェアの世界市場2016-2020About BIM Software Factors, such as government mandates and support to use BIM solutions in construction projects, are driving the growth of the global BIM market. Governments in countries such as the US, the UK, and Singapore are promoting the use of BIM in construction as it helps to minimize errors and time taken for the execution of the construction projects. BIM software enables the creation …
- Red Mountain Resources Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年）Red Mountain Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Red Mountain Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- Cairn Energy PLC：石油・ガスバリューチェーン分析レポート2013Cairn Energy PLC Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Cairn Energy PLC" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Cairn Energy PLC”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the com …
- 防汚塗料の世界市場2016-2020About Antifouling Coatings Antifouling coatings are coatings such as paints are applied to boats, yachts, or ships to reduce the growth of organisms on the part of the ship that is under water and prevent corrosion of metal hulls. Such coatings help in improving the durability and performance of the vessel. In addition, these coatings are also used in fixed and floating offshore oil rigs. Technavi …
- グローバルにおけるクラウド・セキュリティ市場2014：企業とソリューションCloud security is the set of security protocols and technologies that protect the cloud resources and the integrity of data stored in a cloud computing environment. Cloud security differs from traditional computer security in that it is not focused on preventing access to specific machines. This research provides an evaluation of security in cloud computing environment including different types of …
- 半導体レーザー治療の世界市場：美容、手術、眼科、歯科用途About the Semiconductor Laser Treatment Market Medical lasers use focused light sources with precision to treat tissue. A laser light has a specific wavelength in a narrow beam, creating a high-intensity light. The use of lasers in the healthcare sector has proved to be a boon for both the semiconductor and medical industries. Lasers are used in medical treatment areas such as cosmetic dermatology …
- National Fuel Gas Company：石油・ガスバリューチェーン分析レポート2013National Fuel Gas Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "National Fuel Gas Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “National Fuel Gas Company”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. …
- 自動車VVTシステム及びスタート/ストップシステムの世界市場The automotive VVT and start-stop system market is expected to see a considerable growth in countries such as China, India, South Korea, Spain, U.S., and Canada following stringent emission regulations and fuel-efficiency standards enforced by different legislative bodies across the globe, which has forced all OEMs to look for solutions to achieve the same. Thus, the cam-phasing plus changing VVT …
- 高級ハンドバッグの世界市場2019-2023About this market Vendors are constantly reforming and introducing new designs and patterns owing to growing competition and customer demand arising from rapid changes in the fashion industry. Customers seek luxury handbags for formal (especially leather handbags) and casual purposes (such as metal and precious stone studded handbags). To meet such evolving customer needs: vendors regularly expand …
- 魚加工の世界市場：冷凍魚、保存魚The global market for fish processing has been growing steadily during the last few decades. In terms of value, the market is projected to reach USD 222.71 Billion by 2021, at a CAGR of 3.8% from 2016 to 2021 and is projected to reach 37,194.98 KT in terms of volume by 2021, at a CAGR of 2.2%. Factors such as high nutritional profile and added health benefits of processed fish and fish products, g …
- TAED（テトラアセチルエチレンジアミン）の世界市場動向及び予測Tetraacetylethylenediamine (TAED) is a bleach activator that enhances the bleaching effect of the oxygen-based bleach like hydrogen peroxide, at lower temperature. It is a not bleach but needs the presence of oxygen donor to act on the stains effectively. Normally the oxygen bleaching such as using hydrogen peroxide is conducted at high temperatures of 950 C, which has adverse effects on the fabri …
